Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Trippi who wrote (43096)	1/14/1999 10:01:00 AM
From: Gator	Read Replies (1) \| Respond to of 119973

Applied Voice Recognition, Inc. (AVRI) Acquires Medical Transcription Company in Denver, Colorado Internet-based Medical Transcription Company Continues Acquisition Program HOUSTON--(BUSINESS WIRE)--Jan. 14, 1999-- Applied Voice Recognition, Inc. (OTCBB: AVRI - news) announced today that the company has acquired its fourth medical transcription company, based in Denver, Colorado. The acquired operation has contracts with Columbia, Vencor and physician practice groups located in Colorado. Linda Willhite, owner of the acquired company stated, ''AVRI's VoiceCOMMANDER®99 was the key to our decision to sell to AVRI. It's use of secure Internet lines and voice recognition to lower long distance costs and transcription labor costs is a key competitive advantage. We're excited to be part of the AVRI team.'' AVRI Chairman & CEO, Timothy Connolly stated, ''Following the company's earlier 1998 acquisitions in Dallas, New York, and Miami, AVRI finished the year with its fourth major market acquisition in Denver, Colorado. Following the investment by Lernout & Hauspie Investment Company, AVRI intends to continue to complete acquisitions that are accretive to the Company.'' AVRI's plan to acquire medical transcription companies in sixteen major markets was launched in March, 1998. The company now has offices located in five of the targeted market areas, and customers in thirteen states throughout the U.S.A. AVRI plans to implement a common technology platform in all acquisitions based on the company's proprietary transcription product, VoiceCOMMANDER 99. VoiceCOMMANDER 99 is the state of the art technology in medical transcription, utilizing voice recognition, secure Internet communication, and traditional transcription methods to improve the quality and reduce the costs of health care information systems. Subject to the availability of capital, AVRI intends to continue its aggressive acquisition program in 1999. AVRI believes that utilization of the VoiceCOMMANDER 99 system will increase the profit margins of the companies acquired in its acquisition program and deliver acceptable returns on equity for its shareholders. About AVRI AVRI develops and markets innovative voice recognition solutions for the healthcare information technology industry that allow professionals to immediately transform voice dictation into formatted text. Founded in 1994, AVRI has invested in excess of $13 million in voice recognition applications, leading to its focus on the healthcare information technology marketplace. Experience with major voice technology research labs such as Lernout and Hauspie, IBM, Dragon Systems and Philips Dictation provide AVRI with the best industry support available. For more information regarding AVRI, please visit www.voicecommander.com MEDIA ALERT: Tim Connolly will be in New York on Thursday, January 14, 1999 and will be available for interviews. For information, please call Joe Mansi or Jeff Corbin at KCSA Worldwide @ 212-682-6300. This press release contains forward-looking statements relating to future revenues and operating information and their impact on future results. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors such as market conditions, product life cycles, customer delays in purchasing products, technology shifts, potential difficulties in introducing new products, competition, price sensitivity and the uncertainty of continuing market acceptance of the Company's products by distributors, retailers and consumers. Contact: Karen Hott, Investor Relations, 1-888-292-AVRI khott@voicecommander.com